Insulin receptor expression in primary and cultured osteoclast-like cells
- PMID: 9737339
- DOI: 10.1016/s8756-3282(98)00095-7
Insulin receptor expression in primary and cultured osteoclast-like cells
Abstract
Skeletal growth is the net product of coordinated bone formation and resorption. Insulin is known to stimulate bone formation by actions on osteoblasts. It is not known whether insulin receptors are present on osteoclasts, or whether insulin regulates osteoclastic function. We present here immunocytochemical evidence of insulin receptor expression by mature mono- and multinucleated murine osteoclast-like cells generated in vitro, and in primary neonatal rat and mouse osteoclasts. Radiolabeled studies indicated that progressive enrichment of osteoclast-like cells in coculture was associated with increased insulin binding. When osteoclast-like cells generated in vitro were plated onto dentine slices, insulin dose-dependently inhibited pit formation by up to 80%, suggesting a role for insulin in osteoclast function. These data are consistent with an effect of insulin on bone resorption in addition to those previously recognized on bone formation, actions that together result in net bone growth.
Comment in
-
Expression of insulin receptors in osteoclast-like cells.Bone. 1999 Aug;25(2):251. Bone. 1999. PMID: 10456393 No abstract available.
Similar articles
-
Stimulatory effect of insulin-like growth factor binding protein-5 on mouse osteoclast formation and osteoclastic bone-resorbing activity.J Bone Miner Res. 2000 May;15(5):902-10. doi: 10.1359/jbmr.2000.15.5.902. J Bone Miner Res. 2000. PMID: 10804020
-
Osteoblasts mediate insulin-like growth factor-I and -II stimulation of osteoclast formation and function.Endocrinology. 1995 Jan;136(1):124-31. doi: 10.1210/endo.136.1.7828521. Endocrinology. 1995. PMID: 7828521
-
Activation of dimeric glucocorticoid receptors in osteoclast progenitors potentiates RANKL induced mature osteoclast bone resorbing activity.Bone. 2016 Dec;93:43-54. doi: 10.1016/j.bone.2016.08.024. Epub 2016 Sep 2. Bone. 2016. PMID: 27596806
-
Calcitonin responsiveness and receptor expression in porcine and murine osteoclasts: a comparative study.Bone. 1998 Sep;23(3):233-40. doi: 10.1016/s8756-3282(98)00096-9. Bone. 1998. PMID: 9737345
-
The action of GH/IGF-I/IGFBP in osteoblasts and osteoclasts.Horm Res. 1997;48 Suppl 5:45-9. doi: 10.1159/000191328. Horm Res. 1997. PMID: 9434044 Review.
Cited by
-
Effects of distinct Polycystic Ovary Syndrome phenotypes on bone health.Front Endocrinol (Lausanne). 2023 May 12;14:1163771. doi: 10.3389/fendo.2023.1163771. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37251667 Free PMC article. Review.
-
The Impact of Nano-Hydroxyapatite Scaffold Enrichment on Bone Regeneration In Vivo-A Systematic Review.Biomimetics (Basel). 2024 Jun 25;9(7):386. doi: 10.3390/biomimetics9070386. Biomimetics (Basel). 2024. PMID: 39056827 Free PMC article. Review.
-
Effects of peroxisome proliferator-activated receptor-alpha and -gamma agonist, JTT-501, on diabetic complications in Zucker diabetic fatty rats.Br J Pharmacol. 2000 Jun;130(3):495-504. doi: 10.1038/sj.bjp.0703328. Br J Pharmacol. 2000. PMID: 10821776 Free PMC article.
-
Diabetes and disordered bone metabolism (diabetic osteodystrophy): time for recognition.Osteoporos Int. 2016 Jun;27(6):1931-51. doi: 10.1007/s00198-015-3454-x. Epub 2016 Mar 15. Osteoporos Int. 2016. PMID: 26980458 Review.
-
A new perspective on mechanisms governing skeletal complications in type 1 diabetes.Ann N Y Acad Sci. 2016 Nov;1383(1):67-79. doi: 10.1111/nyas.13202. Epub 2016 Aug 29. Ann N Y Acad Sci. 2016. PMID: 27571221 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical